{"log_id": 1513308420617143004, "direction": 0, "words_result_num": 39, "words_result": [{"probability": {"variance": 0.027726, "average": 0.908127, "min": 0.358631}, "location": {"width": 1008, "top": 297, "height": 59, "left": 370}, "words": "阿托他汀对大无作用.以mgkg体计算,大鼠的最大使用剂量比人的最大使"}, {"probability": {"variance": 0.024769, "average": 0.905315, "min": 0.409648}, "location": {"width": 1051, "top": 347, "height": 61, "left": 324}, "words": "用剂量(80mg日)高63倍:以总拟活性推算出的ATC(0-24>值计算,大组数值高"}, {"probability": {"variance": 0.01889, "average": 0.933275, "min": 0.425175}, "location": {"width": 1047, "top": 400, "height": 61, "left": 322}, "words": "出8-16倍。用小进行的一项2年研究中,小鼠的最大使用剂量按mgkg体重计算比人的"}, {"probability": {"variance": 0.020551, "average": 0.913784, "min": 0.509405}, "location": {"width": 1049, "top": 452, "height": 61, "left": 320}, "words": "最大使用剂量高250倍,雄性窗肝纸胞腺瘤和地性鼠开细胞癌的发生率在最大使用剂下增"}, {"probability": {"variance": 0.027679, "average": 0.893686, "min": 0.358856}, "location": {"width": 1047, "top": 505, "height": 61, "left": 320}, "words": "加按AUC(0-24算,小的全身用药量比人的高出6-11倍。在有无代谢激活条件"}, {"probability": {"variance": 0.013201, "average": 0.932191, "min": 0.55257}, "location": {"width": 1028, "top": 560, "height": 57, "left": 322}, "words": "下进行的4项体内试验及1项体外试验都实阿折伐他无致基因突变和致染色体畸变件"}, {"probability": {"variance": 0.005162, "average": 0.956787, "min": 0.63763}, "location": {"width": 1044, "top": 610, "height": 61, "left": 320}, "words": "在动物试验中,雄性动物和雌性动物使用剂量分别高至175mgkg日和225mgkg日,阿托"}, {"probability": {"variance": 0.012113, "average": 0.942541, "min": 0.522022}, "location": {"width": 635, "top": 665, "height": 50, "left": 320}, "words": "伐他汀木对动物的生育能力产兰任何影响,也无致畸性"}, {"probability": {"variance": 0.009356, "average": 0.944629, "min": 0.751465}, "location": {"width": 171, "top": 717, "height": 34, "left": 324}, "words": "药代动力学"}, {"probability": {"variance": 0.019569, "average": 0.917456, "min": 0.400943}, "location": {"width": 1001, "top": 770, "height": 57, "left": 356}, "words": "吸收:阿托伐他汀口服后吸收迅速:1-2小时内药浓度达峰Cmx)。吸收程度阿托"}, {"probability": {"variance": 0.011816, "average": 0.937932, "min": 0.48977}, "location": {"width": 1035, "top": 820, "height": 59, "left": 310}, "words": "伐他汀剂量成正比例增加。与口服溶液剂比,阿托伐他汀片的兰物利月度为95~99"}, {"probability": {"variance": 0.013554, "average": 0.943102, "min": 0.49878}, "location": {"width": 1044, "top": 873, "height": 59, "left": 310}, "words": "对生物利用度约为12%,HM(-CA还原酶扣制活性的全身生物利用度约为30%,全身生"}, {"probability": {"variance": 0.0239, "average": 0.918449, "min": 0.370399}, "location": {"width": 834, "top": 921, "height": 61, "left": 306}, "words": "物利用度较低的原因在一进入体循环前胃肠粘膜消除和成脏首过效应"}, {"probability": {"variance": 0.024142, "average": 0.922765, "min": 0.375796}, "location": {"width": 987, "top": 978, "height": 57, "left": 352}, "words": "分布:阿托他汀的平均分布容积约为381升。98%以上的阿托伐他汀与血浆蛋白结合"}, {"probability": {"variance": 0.020441, "average": 0.928824, "min": 0.44423}, "location": {"width": 989, "top": 1028, "height": 59, "left": 352}, "words": "代谢:阿托伐名由细胞色素P45034代谢成邻位和对位羟基衍生物及多种B氧化产"}, {"probability": {"variance": 0.005812, "average": 0.956114, "min": 0.665963}, "location": {"width": 1044, "top": 1079, "height": 64, "left": 306}, "words": "物。除其他途径外,这些产物还经过葡萄糖醛酸化过程代谢。体外实验中,邹位和对位羟基"}, {"probability": {"variance": 0.010597, "average": 0.948019, "min": 0.60035}, "location": {"width": 1044, "top": 1134, "height": 59, "left": 306}, "words": "化代谢物对 hmg-coa还原酶的制作用与阿托伐他汀相当。对 hmg-coa还原酶的抑制"}, {"probability": {"variance": 0.043766, "average": 0.86083, "min": 0.437881}, "location": {"width": 402, "top": 1188, "height": 36, "left": 304}, "words": "活性约70%是主活性代谢产生的"}, {"probability": {"variance": 0.016587, "average": 0.921354, "min": 0.440719}, "location": {"width": 1001, "top": 1239, "height": 59, "left": 347}, "words": "消除t阿托伐他汀主要经脏和或肝外代谢后经胆汁消除。但阿托伐他汀无明显的肝肠"}, {"probability": {"variance": 0.023239, "average": 0.931455, "min": 0.407527}, "location": {"width": 1051, "top": 1289, "height": 59, "left": 297}, "words": "再循环,阿托伐他汀的平均血浆消除半衰期约为14小时四其活性代流产物的作月,阿托"}, {"probability": {"variance": 0.005876, "average": 0.964072, "min": 0.664871}, "location": {"width": 713, "top": 1342, "height": 50, "left": 297}, "words": "伐汀对 hmg-cua还原酶排制活性的半哀期约为20-30小时"}, {"probability": {"variance": 0.021554, "average": 0.854375, "min": 0.672877}, "location": {"width": 112, "top": 1399, "height": 34, "left": 340}, "words": "特殊人群"}, {"probability": {"variance": 0.022582, "average": 0.937793, "min": 0.393114}, "location": {"width": 1003, "top": 1447, "height": 59, "left": 340}, "words": "老年人:健康老年受试者托伐他汀及其活性代谢产物的血浆浓度高于年轻成受试"}, {"probability": {"variance": 0.00587, "average": 0.915773, "min": 0.839154}, "location": {"width": 50, "top": 1481, "height": 32, "left": 1534}, "words": "丸彳"}, {"probability": {"variance": 0.010802, "average": 0.943891, "min": 0.6564}, "location": {"width": 379, "top": 1502, "height": 41, "left": 292}, "words": "者,但降脂效果与年轻患者相当"}, {"probability": {"variance": 0.011018, "average": 0.925937, "min": 0.666376}, "location": {"width": 452, "top": 1552, "height": 45, "left": 340}, "words": "儿童:尚无儿童人群的药代动力学资料"}, {"probability": {"variance": 0.010633, "average": 0.964105, "min": 0.514902}, "location": {"width": 896, "top": 1604, "height": 54, "left": 338}, "words": "性别:女性的阿托伐他汀及其活性代谢产物的止浆浓度与男性的不同〔在女性"}, {"probability": {"variance": 0, "average": 0.948105, "min": 0.948105}, "location": {"width": 27, "top": 1630, "height": 27, "left": 1312}, "words": "增"}, {"probability": {"variance": 0.037098, "average": 0.886878, "min": 0.377749}, "location": {"width": 1154, "top": 1653, "height": 123, "left": 288}, "words": "如约20%AL降低10%,这些差异无临床显著性,因性和女性的路脂效临"}, {"probability": {"variance": 0, "average": 0.874415, "min": 0.874415}, "location": {"width": 73, "top": 1659, "height": 29, "left": 1310}, "words": " LACEU"}, {"probability": {"variance": 0.000121, "average": 0.99101, "min": 0.975545}, "location": {"width": 134, "top": 1710, "height": 32, "left": 290}, "words": "显性差"}, {"probability": {"variance": 0.033786, "average": 0.88052, "min": 0.399302}, "location": {"width": 1063, "top": 1755, "height": 66, "left": 329}, "words": "肾功能不全思者:肾腺疾病对阿托伐他汀及共活性代产幼的血浆浓度及效果无仁公"}, {"probability": {"variance": 0.0001, "average": 0.96342, "min": 0.950556}, "location": {"width": 82, "top": 1815, "height": 32, "left": 288}, "words": "何影响"}, {"probability": {"variance": 0, "average": 0.706253, "min": 0.706253}, "location": {"width": 192, "top": 1838, "height": 57, "left": 1188}, "words": " PHA8MACEUTIO"}, {"probability": {"variance": 0.0275, "average": 0.873381, "min": 0.455065}, "location": {"width": 1099, "top": 1845, "height": 244, "left": 331}, "words": "日尚无不良事件报行本品灯患者的驾驶能力和操作机器的能力产生任何影响"}, {"probability": {"variance": 0.040525, "average": 0.849015, "min": 0.355484}, "location": {"width": 1033, "top": 1863, "height": 66, "left": 329}, "words": "肝功能不全者:慢性酒精性升病患老( childs-'u分级B)中阿括伐他及性制"}, {"probability": {"variance": 0.027707, "average": 0.888004, "min": 0.40453}, "location": {"width": 672, "top": 1918, "height": 52, "left": 281}, "words": "产物的血浆浓度显著升高(Cmax约16倍,AC约11倍)"}, {"probability": {"variance": 0.003698, "average": 0.973009, "min": 0.767662}, "location": {"width": 386, "top": 1973, "height": 43, "left": 292}, "words": "【对驾车操作机器能力的影】"}, {"probability": {"variance": 0.06864, "average": 0.728733, "min": 0.46674}, "location": {"width": 107, "top": 1957, "height": 48, "left": 1209}, "words": "官公"}], "language": 3}